115 related articles for article (PubMed ID: 32296042)
1. Inhibition of USP14 and UCH37 deubiquitinating activity by b-AP15 as a potential therapy for tumors with p53 deficiency.
Ma YS; Wang XF; Yu F; Wu TM; Liu JB; Zhang YJ; Xia Q; Jiang ZY; Lin QL; Fu D
Signal Transduct Target Ther; 2020 Apr; 5(1):30. PubMed ID: 32296042
[No Abstract] [Full Text] [Related]
2. Treatment with b-AP15 to Inhibit UCHL5 and USP14 Deubiquitinating Activity and Enhance p27 and Cyclin E1 for Tumors with
Jiang ZY; Hong J; Zhang JH; Wang XF; Ma YS; Xiong ZX; Sun HR; Cheng C; Xie BZ; Liu JB; Ouyang YG; Fu D
Technol Cancer Res Treat; 2022; 21():15330338221119745. PubMed ID: 35971329
[No Abstract] [Full Text] [Related]
3. Deubiquitylatinase inhibitor b-AP15 induces c-Myc-Noxa-mediated apoptosis in esophageal squamous cell carcinoma.
Sha B; Chen X; Wu H; Li M; Shi J; Wang L; Liu X; Chen P; Hu T; Li P
Apoptosis; 2019 Oct; 24(9-10):826-836. PubMed ID: 31342239
[TBL] [Abstract][Full Text] [Related]
4. Targeting the Proteasome-Associated Deubiquitinating Enzyme USP14 Impairs Melanoma Cell Survival and Overcomes Resistance to MAPK-Targeting Therapies.
Didier R; Mallavialle A; Ben Jouira R; Domdom MA; Tichet M; Auberger P; Luciano F; Ohanna M; Tartare-Deckert S; Deckert M
Mol Cancer Ther; 2018 Jul; 17(7):1416-1429. PubMed ID: 29703842
[TBL] [Abstract][Full Text] [Related]
5. Targeted inhibition of the deubiquitinating enzymes, USP14 and UCHL5, induces proteotoxic stress and apoptosis in Waldenström macroglobulinaemia tumour cells.
Chitta K; Paulus A; Akhtar S; Blake MK; Caulfield TR; Novak AJ; Ansell SM; Advani P; Ailawadhi S; Sher T; Linder S; Chanan-Khan A
Br J Haematol; 2015 May; 169(3):377-90. PubMed ID: 25691154
[TBL] [Abstract][Full Text] [Related]
6. Proteasomal cysteine deubiquitinase inhibitor b-AP15 suppresses migration and induces apoptosis in diffuse large B cell lymphoma.
Jiang L; Sun Y; Wang J; He Q; Chen X; Lan X; Chen J; Dou QP; Shi X; Liu J
J Exp Clin Cancer Res; 2019 Nov; 38(1):453. PubMed ID: 31694672
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitin-specific protease 14 regulates cell proliferation and apoptosis in oral squamous cell carcinoma.
Chen X; Wu J; Chen Y; Ye D; Lei H; Xu H; Yang L; Wu Y; Gu W
Int J Biochem Cell Biol; 2016 Oct; 79():350-359. PubMed ID: 27592452
[TBL] [Abstract][Full Text] [Related]
8. Expression profiling reveals transcriptional regulation by Fbxw7/mTOR pathway in radiation-induced mouse thymic lymphomas.
Snijders AM; Liu Y; Su L; Huang Y; Mao JH
Oncotarget; 2015 Dec; 6(42):44794-805. PubMed ID: 26575021
[TBL] [Abstract][Full Text] [Related]
9. Novel therapeutic interventions for p53-altered tumors through manipulation of its family members, p63 and p73.
Venkatanarayan A; Raulji P; Norton W; Flores ER
Cell Cycle; 2016; 15(2):164-71. PubMed ID: 26652033
[TBL] [Abstract][Full Text] [Related]
10. Emerging role of ubiquitin-specific protease 14 in oncogenesis and development of tumor: Therapeutic implication.
Liu B; Chen J; Zhang S
Life Sci; 2019 Dec; 239():116875. PubMed ID: 31676235
[TBL] [Abstract][Full Text] [Related]
11. Deubiquitinase inhibitor b-AP15 activates endoplasmic reticulum (ER) stress and inhibits Wnt/Notch1 signaling pathway leading to the reduction of cell survival in hepatocellular carcinoma cells.
Ding Y; Chen X; Wang B; Yu B; Ge J
Eur J Pharmacol; 2018 Apr; 825():10-18. PubMed ID: 29454609
[TBL] [Abstract][Full Text] [Related]
12. Ubiquitin-specific protease 14 regulates c-Jun N-terminal kinase signaling at the neuromuscular junction.
Vaden JH; Bhattacharyya BJ; Chen PC; Watson JA; Marshall AG; Phillips SE; Wilson JA; King GD; Miller RJ; Wilson SM
Mol Neurodegener; 2015 Jan; 10():3. PubMed ID: 25575639
[TBL] [Abstract][Full Text] [Related]
13. Function of Deubiquitinating Enzyme USP14 as Oncogene in Different Types of Cancer.
Zhu Y; Zhang C; Gu C; Li Q; Wu N
Cell Physiol Biochem; 2016; 38(3):993-1002. PubMed ID: 26938858
[TBL] [Abstract][Full Text] [Related]
14. The Deubiquitinating Enzyme USP14 Regulates Leukemic Chemotherapy Drugs-Induced Cell Apoptosis by Suppressing Ubiquitination of Aurora Kinase B.
Song C; Ma R; Yang X; Pang S
Cell Physiol Biochem; 2017; 42(3):965-973. PubMed ID: 28662510
[TBL] [Abstract][Full Text] [Related]
15. The 19S Deubiquitinase inhibitor b-AP15 is enriched in cells and elicits rapid commitment to cell death.
Wang X; Stafford W; Mazurkiewicz M; Fryknäs M; Brjnic S; Zhang X; Gullbo J; Larsson R; Arnér ES; D'Arcy P; Linder S
Mol Pharmacol; 2014 Jun; 85(6):932-45. PubMed ID: 24714215
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of USP14 Deubiquitinating Activity as a Potential Therapy for Tumors with
Ma YS; Wang XF; Zhang YJ; Luo P; Long HD; Li L; Yang HQ; Xie RT; Jia CY; Lu GX; Chang ZY; Zhang JJ; Xue SB; Lv ZW; Yu F; Xia Q; Fu D
Mol Ther Oncolytics; 2020 Mar; 16():147-157. PubMed ID: 32055678
[TBL] [Abstract][Full Text] [Related]
17. Lysine-specific demethylase 1 accelerates oncogenesis in p53 heterozygous mice via transcriptional repression of the residual Trp53 allele.
Wada T; Kikuchi J; Koyama D; Honda H; Furukawa Y
Leuk Res; 2019 Jul; 82():29-32. PubMed ID: 31152920
[No Abstract] [Full Text] [Related]
18. Therapeutic Response to Non-genotoxic Activation of p53 by Nutlin3a Is Driven by PUMA-Mediated Apoptosis in Lymphoma Cells.
Valente LJ; Aubrey BJ; Herold MJ; Kelly GL; Happo L; Scott CL; Newbold A; Johnstone RW; Huang DC; Vassilev LT; Strasser A
Cell Rep; 2016 Mar; 14(8):1858-66. PubMed ID: 26904937
[TBL] [Abstract][Full Text] [Related]
19. USP14 Inhibition Regulates Tumorigenesis by Inducing Autophagy in Lung Cancer In Vitro.
Han KH; Kwak M; Lee TH; Park MS; Jeong IH; Kim MJ; Jin JO; Lee PC
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31653087
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of ubiquitin specific peptidase 14 predicts unfavorable prognosis in esophageal squamous cell carcinoma.
Zhang B; Li M; Huang P; Guan XY; Zhu YH
Thorac Cancer; 2017 Jul; 8(4):344-349. PubMed ID: 28509417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
